Virtual event – Thursday 21 October 13:00-15:30 GMT
3 CPD points
 

This afternoon virtual event, will focus on two aspects of MRI - Whole-body PET and simultaneous MRI and Whole-body MRI. Please see further details on the topics covered below.

View programme here

Whole-body PET with 18F-FDG forms part of national and international recommendations for staging patients with cancer and monitoring progress after treatment. Contemporary PET/CT protocols consist of vertex to mid-thigh field of view with CT and PET acquired sequentially. Both a low- and high-resolution CT are acquired for attenuation correction and anatomical localisation, respectively. Tumour metabolism information is the displayed in standardised uptake value maps superimposed on to the high-resolution CT images for the purposes of clinical reporting. However, with the development of commercial hybrid PET/MRI scanners some decade or so ago, these PET images can now be married-up with WB-MRI protocols which include diffusion-weighted MRI and Dixon MRI, to provide complementary morphological and tissue structure whole-body imaging for assessment. In this talk we will discuss the indications for simultaneous PET/MRI, and describe some protocols and the physical principles of PET with MR attenuation correction maps, and discuss the clinical interpretation of PET/MRI for patients with metastatic disease.

Educational aims:

1. Discuss current status for use of PET/MRI in oncological applications.
2. Understand how to set up PET/MRI protocols, including common artefacts and pitfalls.
3. Understand physical principles of Dixon (fat/water) imaging in relation to attenuation correction maps required for reconstruction of PET images.
4. Understand how to interpret findings in PET/MRI.

Whole-body magnetic resonance imaging (WB-MRI) forms part of national and international recommendations for imaging patients with myeloma or metastatic prostate cancer. Contemporary WB-MRI protocols, which include diffusion-weighted MRI and Dixon MRI, provide complementary morphological and functional whole-body imaging for assessment of the extent of systemic malignant bone disease and response to treatment. In this talk we will discuss the indications for WB-MRI, describe WB-MRI protocols and the physical principles of diffusion-weighted MRI and Dixon imaging, and discuss the clinical interpretation of WB-MRI for patients with malignant bone disease.

Educational aims:

1. Understand current guidelines for use of whole-body MRI (WB-MRI) in oncological applications.
2. Understand how to set up WB-MRI protocols on modern MRI scanners, including common artefacts and pitfalls.
3. Understand physical principles of diffusion-weighted MRI and Dixon (fat/water) imaging.
4. Understand how to interpret findings in WB-MRI.

EARLY BIRD Registration fees:
Non members £95
Plan 1 members £60
Plan 2/Trainee members £50
Retired/student member £40
*EARLY BIRD rates expire on Friday 15 October

Registration fees:
Non members £100
Plan 1 members £65
Plan 2/Trainee members £55
Retired/student member £45

Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees please have them contact our events team at conference@bir.org.uk. For any further inquiries please contact conference@bir.org.uk
 
If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email conference@bir.org.uk 

Please ensure that you have read the events terms and conditions here, before booking onto an event.